|
⚲
|
| Keyboard |
| Milano Vincent
✚
|
|
|---|---|
| CIK # | 0001187159 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001187159] | |
| 4 | [0001187159] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Milano Vincent | |
| Biocryst Pharmaceuticals Inc | |
| Aclaris Therapeutics Inc | |
| Idera Pharmaceuticals Inc | |
| Spark Therapeutics Inc | |
| Vanda Pharmaceuticals Inc | |
| Viropharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2026-02-27 | Grant | 848 | $8.75 | 7,420 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2025-11-28 | Grant | 783 | $7.18 | 5,622 |
|
Biocryst Pharmaceuticals Inc BCRX
Automatic Stock Option Grant · derivative
|
2025-06-12 | Grant | 27,181 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2025-06-12 | Grant | 12,500 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Common Stock
|
2025-06-06 | Option exercise | 4,793 | ||
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2025-06-06 | Option exercise | 4,793 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2025-06-05 | Grant | 11,580 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Stock Option (Right to Buy) · derivative
|
2025-06-05 | Grant | 42,350 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2025-05-30 | Grant | 523 | $10.75 | 5,622 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2025-02-28 | Grant | 653 | $8.61 | 5,622 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-11-29 | Grant | 750 | $7.50 | 5,625 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-08-30 | Grant | 647 | $8.69 | 5,622 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-06-12 | Grant | 6,820 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Automatic Stock Option Grant · derivative
|
2024-06-12 | Grant | 49,933 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2024-06-06 | Grant | 4,793 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Stock Option (Right to Buy) · derivative
|
2024-06-06 | Grant | 15,750 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Common Stock
|
2024-06-01 | Option exercise | 4,660 | ||
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2024-06-01 | Option exercise | 4,660 | $0.00 | |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-05-31 | Grant | 870 | $6.46 | 5,620 |
|
Biocryst Pharmaceuticals Inc BCRX
Common Stock
|
2024-05-20 | Buy | 15,000 | $6.25 | 93,750 |
| showing 20 of 173 most recent transactions | |||||